The Vps13-like protein BLTP2 is pro-survival and regulates phosphatidylethanolamine levels in the plasma membrane to maintain its fluidity and function

Subhrajit Banerjee,Stephan Daetwyler,Xiaofei Bai,Morgane Michaud,Juliette Jouhet,Shruthi Madhugiri,Emma Johnson,Chao-Wen Wang,Reto Fiolka,Alexandre Toulmay,William A. Prinz

DOI: https://doi.org/10.1101/2024.02.04.578804

2024-02-05

Abstract:Lipid transport proteins (LTPs) facilitate nonvesicular lipid exchange between cellular compartments and have critical roles in lipid homeostasis . A new family of bridge-like LTPs (BLTPs) is thought to form lipid-transporting conduits between organelles . One, BLTP2, is conserved across species but its function is not known. Here, we show that BLTP2 and its homolog directly regulate plasma membrane (PM) fluidity by increasing the phosphatidylethanolamine (PE) level in the PM. BLTP2 localizes to endoplasmic reticulum (ER)-PM contact sites , suggesting it transports PE from the ER to the PM. We find BLTP2 works in parallel with another pathway that regulates intracellular PE distribution and PM fluidity . BLTP2 expression correlates with breast cancer aggressiveness . We found BLTP2 facilitates growth of a human cancer cell line and sustains its aggressiveness in an in vivo model of metastasis, suggesting maintenance of PM fluidity by BLTP2 may be critical for tumorigenesis in humans.

Cell Biology

What problem does this paper attempt to address?

The paper aims to explore the function of the Vps13-like protein BLTP2 and its role in cell membrane phospholipid metabolism and cancer progression. Specifically, the researchers attempt to address the following questions: 1. **The role of BLTP2 in cell membrane phospholipid metabolism**: The researchers found that BLTP2 can regulate the levels of phosphatidylethanolamine (PE) in the cell membrane, thereby maintaining the fluidity and function of the cell membrane. They experimentally verified the localization of BLTP2 at the contact points between the endoplasmic reticulum (ER) and the plasma membrane (PM), suggesting that it may achieve this function by transporting PE from the ER to the PM. 2. **The conservation and function of BLTP2 in different organisms**: The researchers studied the function of BLTP2 not only in human cells but also in model organisms such as yeast and nematodes to verify the conservation of BLTP2 function. The results showed that BLTP2 has similar functions in different species, affecting cell membrane fluidity by regulating PE levels. 3. **The role of BLTP2 in cancer**: The researchers found that the expression of BLTP2 is associated with the invasiveness of breast cancer, and knocking out BLTP2 in human breast cancer cell lines significantly reduced the proliferation rate and invasiveness of the cells. Additionally, they further confirmed the impact of BLTP2 on tumor cell migration and invasion using a zebrafish xenotransplantation model. 4. **The relationship between BLTP2 and other lipid metabolism pathways**: The researchers also explored whether BLTP2 interacts with other known pathways that regulate cell membrane fluidity. The results showed that BLTP2 works in conjunction with the TLCD1 protein to independently regulate cell membrane fluidity, indicating that cells may have multiple mechanisms to ensure sufficient PE in the cell membrane. In summary, the paper primarily addresses the specific function of BLTP2 in cell membrane phospholipid metabolism and its potential role in cancer progression. These findings provide new insights into the regulatory mechanisms of cell membrane lipid metabolism and may offer a theoretical basis for developing new cancer treatment strategies.

The Vps13-like protein BLTP2 is pro-survival and regulates phosphatidylethanolamine levels in the plasma membrane to maintain its fluidity and function

Withdrawal: A Novel Human Phosphatidylethanolamine-Binding Protein Resists Tumor Necrosis Factor Α-Induced Apoptosis by Inhibiting Mitogen-Activated Protein Kinase Pathway Activation and Phosphatidylethanolamine Externalization.

Bridge-like lipid transfer protein family member 2 suppresses ciliogenesis

Bridge-like lipid transfer protein 3A (BLTP3A) is associated with membranes of the late endocytic pathway and is an effector of CASM

Structural basis of bulk lipid transfer by bridge-like lipid transfer protein LPD-3

Abstract 330: Liver-Specific Phospholipids Transfer Protein Activity Has Significant Contribution in Hepatocyte Apob-Containing Lipoprotein Production and in Plasma Lipoprotein Metabolism

A system-wide analysis of lipid transfer proteins delineates lipid mobility in human cells

Targeted Mutation of Plasma Phospholipid Transfer Protein Gene Markedly Reduces High-Density Lipoprotein Levels.

PTP4A2 promotes lysophagy by dephosphorylation of VCP/p97 at Tyr805

The Binding Capability of Plasma Phospholipid Transfer Protein, but Not Hdl Pool Size, is Critical to Repress Lps Induced Inflammation

The Effect of Phospholipid Transfer Protein on Lipoprotein Metabolism and Atherosclerosis

Pla2g12b drives expansion of triglyceride-rich lipoproteins

A conserved protein tyrosine phosphatase, PTPN-22, functions in diverse developmental processes in

Delayed recruiting of TPD52 to lipid droplets – evidence for a “second wave” of lipid droplet-associated proteins that respond to altered lipid storage induced by Brefeldin A treatment

Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells

The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme

Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity

Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate

The Second Sphere Residue T263 is Important for Function and Activity of PTP1B Through Modulating WPD Loop

Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.